Science Daily: Pharmacology News
MARCH 3, 2025
Research has shown that tattoo ink does not just remain where it is injected. Particles from the ink can migrate to the lymph nodes, where they accumulate.
Drugs.com
MARCH 3, 2025
MONDAY, March 3, 2025 -- More than a third of food-allergic kids were able to eat full servings of their trigger foods after treatment with an injectable asthma drug, new clinical trial findings report. In all, 36% of children treated with.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Science Daily: Pharmacology News
MARCH 3, 2025
Distressing news and traumatic stories can cause stress and anxiety -- not only in humans, but these stories can also affect AI language models, such as ChatGPT. Researchers have now shown that these models, like humans, respond to therapy: an elevated 'anxiety level' in GPT-4 can be 'calmed down' using mindfulness-based relaxation techniques.
Covalent Modifiers
MARCH 3, 2025
Marco Paolino, Giusy Tassone, Paolo Governa, Mario Saletti, Matteo Lami, Riccardo Carletti, Filippo Sacchetta, Cecilia Pozzi, Maurizio Orlandini, Fabrizio Manetti, Massimo Olivucci, and Andrea Cappelli ACS Medicinal Chemistry Letters 2025 DOI: 10.1021/acsmedchemlett.4c00479 The use of Targeted Covalent Inhibitors (TCIs) is an expanding strategy for the development of innovative drugs.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Science Daily: Pharmacology News
MARCH 3, 2025
As highly pathogenic H5N1 avian influenza continues to spread in the U.S., posing serious threats to dairy and poultry farms, both farmers and public health experts need better ways to monitor for infections, in real time, to mitigate and respond to outbreaks. Newly devised virus trackers can monitor for airborne particles of H5N1.
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
Science Daily: Pharmacology News
MARCH 3, 2025
Melting ice sheets are slowing the Antarctic Circumpolar Current (ACC), the world's strongest ocean current, researchers have found. This melting has implications for global climate indicators, including sea level rise, ocean warming and viability of marine ecosystems. The researchers have shown the current slowing by around 20 per cent by 2050 in a high carbon emissions scenario.
Drugs.com
MARCH 3, 2025
MONDAY, March 3, 2025 -- Heard the latest on social media about testosterone testing, full-body MRI scans, egg timer female fertility tests or gut microbiome analysis?If so, youve more than likely been exposed to misinformation, a new study sugge.
BioPharma Drive: Drug Pricing
MARCH 3, 2025
Callio Therapeutics is launching with an ADC technology and programs licensed from Singapore-based antibody drug developer Hummingbird Bioscience.
Drugs.com
MARCH 3, 2025
MONDAY, March 3, 2025 -- In a policy statement published today in the Federal Register, Robert F. Kennedy Jr., secretary of the U.S. Department of Health and Human Services, has rescinded the current policy of requiring new rules and regulations to.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Science Daily: Pharmacology News
MARCH 3, 2025
Overnight bursts of brain waves seen in normal sleep can help doctors predict which unresponsive patients hospitalized with acute severe brain injuries will awaken and eventually recover.
Drugs.com
MARCH 3, 2025
MONDAY, March 3, 2025 -- More than a third of food-allergic kids were able to eat full servings of their trigger foods after treatment with an injectable asthma drug, new clinical trial findings report.In all, 36% of children treated with.
BioPharma Drive: Drug Pricing
MARCH 3, 2025
A licensing deal with Denmark’s Gubra gives the immunology giant control of an experimental therapy that could compete with drugs from Novo Nordisk, Eli Lilly and Zealand.
Drugs.com
MARCH 3, 2025
MONDAY, March, 3, 2025 -- In a groundbreaking series of surgeries, doctors at Duke Health have successfully performed the worlds first living mitral valve replacement, saving the lives of three young girls across North Carolina.The procedure b.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Drug Patent Watch
MARCH 3, 2025
Breaking Down Barriers: The Power of Global Research Collaborations in Generic Drug Development As the world grapples with the complexities of healthcare, one thing is clear: the need for innovative solutions has never been more pressing. In the realm of generic drug development, international research collaborations are emerging as a game-changer. By pooling resources, expertise, and knowledge, researchers from around the globe can accelerate the discovery of life-saving treatments and make the
Drugs.com
MARCH 3, 2025
MONDAY, March 3, 2025 -- As electric vehicles (EVs) become more common on roads, they bring new health concerns for firefighters and the community, new research shows.Researchers at the University of Miami's Sylvester Comprehensive Cancer Center.
BioPharma Drive: Drug Pricing
MARCH 3, 2025
Takeda paid Protagonist $300 million one year ago to license rights to rusfertide, which the companies are developing to treat polycythemia vera.
Drugs.com
MARCH 3, 2025
MONDAY, March 3, 2025 -- Suicide prevention campaigns are overlooking seniors, even though people 75 and older have the highest rates of suicide for any age group, a new study says.None of the seven most prominent suicide prevention programs.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Drug Target Review
MARCH 3, 2025
The search for effective treatments for neurodegenerative diseases like Parkinson’s disease has long been hindered by the brain’s complexity and the absence of adequate models for drug discovery. Turning this tide, Professor Jens Christian Schwamborn, a cell biology expert at the University of Luxembourg and co-founder of OrganoTherapeutics , is leading a groundbreaking effort to transform our understanding and treatment of these debilitating diseases.
Drugs.com
MARCH 3, 2025
MONDAY, March 3, 2025 -- Physical activity can improve the mental well-being of women living with chronic pelvic pain disorders like endometriosis and uterine fibroids, a new study says.Activities like brisk walking or aerobic exercise caused.
Drug Patent Watch
MARCH 3, 2025
Unlock the Power of Google Patents for Drug Patent Research As a researcher or professional in the pharmaceutical industry, staying on top of the latest developments in drug patents is crucial for making informed decisions. But with the vast amount of information available, it can be overwhelming to know where to start. That's where Google Patents comes in a powerful tool that can help you streamline your research and uncover valuable insights.
Drugs.com
MARCH 3, 2025
MONDAY, March 3, 2025 -- Dr. Francis Collins, the famed geneticist who led the National Institutes of Health (NIH) for 12 years and helped guide the U.S. through the COVID pandemic, has stepped down.Collins, who's 74, announced his retirement over.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Crown Bioscience
MARCH 3, 2025
The tumor microenvironment (TME) has emerged as a critical player in cancer biology, influencing tumor growth, progression, and response to therapy. Its heterogeneity varies significantly across different cancer types, with variations in stromal cell composition, immune infiltration, and extracellular matrix (ECM) dynamics. For example, pancreatic tumors often exhibit a dense desmoplastic stroma dominated by cancer-associated fibroblasts (CAFs), while lung tumors may feature a higher proportion
H1 Blog
MARCH 3, 2025
How Deeper Data Insights Are Driving Impact at Johnson & Johnson As the role of Medical Affairs continues to evolve, data plays an increasingly critical role in shaping key opinion leader (KOL) engagement strategies, identifying care gaps, and ensuring equitable healthcare delivery. At Johnson & Johnson (J&J), Jennifer Wheeler , Associate Director of Analytics in Immunology Medical Affairs, has been at the forefront of leveraging data to drive smarter, more impactful decision-making.
Perficient: Drug Development
MARCH 3, 2025
As I gear up for my presentation at the Adobe Summit this March, Ive been reflecting on the transformative potential of a well-executed content supply chainand the hurdles large organizations face in making it a reality. And since it is Summit, I will obviously be referencing tools like Adobe GenStudio, Adobe Workfront, AEM Sites, and AEM Assets, which all aim to streamline content creation, management, and activation.
DS in Pharmatics
MARCH 3, 2025
Qualified person (QP) certification and declaration are distinct in their objectives within pharmaceutical and biotech industries. However, their similar names and overlapping functions can lead to confusion – particularly for those outside the EU/UK regulatory framework.
Reprocell
MARCH 3, 2025
Prince Georges (PG) County, Maryland has an advantage; geographically, it is perfectly situated between Washington, DC and Baltimore, Maryland. The proximity to the federal government, the Port of Baltimore, and major interstate routes make the region an ideal location for economic opportunities for a variety of industries. The county already has major points of interest including Northwest Stadium (home of the Washington Commanders), NASA Goddard Space Flight Center, the MGM National Harbor, Jo
FDA Law Blog: Drug Discovery
MARCH 3, 2025
The American Conference Institutes 3rd Annual Forum on Advanced Therapeutics is scheduled to take place from March 19-20, 2025, at the Seaport Hotel in Boston, MA. The conference will bring together industry leaders to explore evolving market trends, regulatory frameworks, and intellectual property strategies shaping the future of advanced therapeutics.
Zobio
MARCH 3, 2025
In person Molecular glues and targeted protein degraders are revolutionizing the field of drug discovery, offering promising solutions for a range of diseases, including cancer, infectious, inflammatory, and neurodegenerative diseases. These innovative therapies are particularly beneficial for targeting previously undruggable pathogenic proteins. The recent emergence of the molecular glue class of protein degraders is paving.
DrugBank
MARCH 3, 2025
In the fast-paced world of pharmaceutical research and drug development, clarity and efficiency are everything. Yet, too often, researchers are left grappling with fragmented data sources, manual workflows, and missed opportunities. That’s why we’re thrilled to introduce the next evolution of DrugBank - a groundbreaking intelligence platform designed to revolutionize how scientists and biotech professionals uncover insights, streamline decision-making, and accelerate drug discovery
Expert insights. Personalized for you.
324 
Let's personalize your content